Found 22 articles for: "sarecycline"
FULL SUPPLEMENT: Looking Beyond the Skin, Examining the Patient and Clinician Reported Outcomes and Effects of Acne Vulgaris and Sarecycline Treatment
February 2024 | Volume 23 | Issue 2 | Department | SF405634s1 | Copyright © February 2024
Background: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients' functioning and activities of daily living (A...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter!
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF378969s3 | Copyright © February 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s12 | Copyright © February 2024
Background: Patient-reported outcomes (PROs) are emerging as a fundamental component of disease impact assessment in acne vulgaris (AV), complementing clinician-reported outcomes...
Read MoreINDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s5 | Copyright © February 2024
Background: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients’ functioning and activities of daily liv...
Read MoreINDIVIDUAL ARTICLE: Assessing the Impact of Acne and Its Treatment on Disease Burden and Quality of Life
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s4 | Copyright © February 2024
Sarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Ensuring Dermatologists Practice Enhanced Antibiotic Stewardship With Sarecycline Mnemonic
October 2023 | Volume 22 | Issue 10 | Editorials | 1061 | Copyright © October 2023
It must be ensured that dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis. In order to help achieve this, we ...
Read MoreTrends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016
March 2023 | Volume 22 | Issue 3 | Original Article | 265 | Copyright © March 2023
Background: Antibiotic resistance related to prolonged antibiotic use is an emerging threat to public health. Objective: To evaluate recent trends in oral antibiotic use for acne trea...
Read MoreSUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene
December 2022 | Volume 21 | Issue 12 | Supplement Individual Articles | SF3446185 | Copyright © December 2022
Acne vulgaris of the trunk carries with it a major psychosocial impact and an unmet need for adequate management. Approximately 50% of patients with facial acne also exhibit involvement of the back, c...
Read MoreSupplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens
September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3595563 | Copyright © September 2022
Introduction: Rosacea is a chronic condition involving inflammation leading to a diminished skin barrier function in sebaceous gland-rich facial skin. The current algorithm represents...
Read MoreA Rare Case of Empedobacter Brevis Cutaneous Infection Treated Successfully With Oral Sarecycline
February 2022 | Volume 21 | Issue 2 | Case Reports | 201 | Copyright © February 2022
Empedobacter brevis (E. brevis) is a gram-negative, nonmotile, aerobic bacteria that is part of the Flavobacteriaceae family. It is mostly found in water sources, plants, soils, and more recently, hos...
Read MoreFifty Years of Minocycline and Its Evolution: A Dermatological Perspective
October 2021 | Volume 20 | Issue 10 | Original Article | 1031 | Copyright © October 2021
2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used...
Read MoreAcne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance
June 2021 | Volume 20 | Issue 6 | Original Article | 648 | Copyright © June 2021
Background: The Food and Drug Administration (FDA) recommends grading Acne vulgaris via an Investigator’s Global Assessment (IGA) scale and assessing treatment as either success...
Read MoreManagement of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials
June 2021 | Volume 20 | Issue 6 | Original Article | 634 | Copyright © June 2021
Background: Acne vulgaris is a common skin disease that affects the face, chest, and back. While truncal acne is present in at least 50% of patients, clinical studies have focused pre...
Read MoreOral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety
April 2021 | Volume 20 | Issue 4 | Original Article | 426 | Copyright © April 2021
Background: Cutaneous rosacea is a common inflammatory skin disorder that often presents with facial papulopustular lesions that are frequently bothersome to patients. Studies have sh...
Read MoreSuccessful Treatment of Periorificial Dermatitis With Novel Narrow Spectrum Sarecycline
January 2021 | Volume 20 | Issue 1 | Case Reports | 98 | Copyright © January 2021
Broad spectrum tetracyclines are a well-known, widely used, and often successful treatment for use in inflammatory skin pathologies such as acne and rosacea. However, the steady rise of antibiotic res...
Read MoreARTICLE: Oral Tetracyclines and Acne: A Systematic Review for Dermatologists
November 2020 | Volume 19 | Issue 11 | Supplement Individual Articles | s6 | Copyright © November 2020
Oral tetracyclines are the most widely prescribed systemic antibiotic for acne. Synthesis of efficacy and safety of traditional and novel oral tetracyclines is highly informative to clinical practice....
Read MoreARTICLE: A Novel Antibiotic Just for Acne
November 2020 | Volume 19 | Issue 11 | Supplement Individual Articles | s5 | Copyright © November 2020
Dermatologists consistently rank as the most frequent prescribers of systemic antibiotics, and one of the most common diagnoses for which we recommend these agents is acne vulgaris. Up to three quarte...
Read MoreConsensus on Neonatal Through Preadolescent Acne
June 2020 | Volume 19 | Issue 6 | Original Article | 592 | Copyright © June 2020
Background: Acne vulgaris is the most common dermatological disorder. Pediatric acne may be a manifestation of the underlying pathology and can occur in the first weeks, months, or ye...
Read MoreUnited States Stock Market Response to FDA Approval of New Dermatologic Drugs
June 2020 | Volume 19 | Issue 6 | Original Article | 639 | Copyright © June 2020
Background: The Food and Drug Administration (FDA) has approved several new dermatologic drugs in the last decade. The public response to their approval has not yet been evaluated.
Media and other results for: "sarecycline"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.